[1]
W. Gulzar, Z. Niaz, S. U. Mumtaz, S. Iqtadar, T. Komal, and S. Abaidullah, “Efficacy of Atorvastatin Plus Pegylated Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin Alone in Chronic Hepatitis C Patients with Genotype-3a: Atorvastatin for the treatment of chronic HCV with Genotype-3a”, PBMJ, vol. 2, no. 1, Jun. 2019, doi: 10.52229/pbmj.v2i1.28.